Dan Wang
Impact in
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
- Nephrology 31
- Chronic Kidney Disease and Diabetes 8
- Dialysis and Renal Disease Management 7
- Gout, Hyperuricemia, Uric Acid 7
-
- Cardiovascular Health and Disease Prevention 13
- Blood Pressure and Hypertension Studies 7
- Co-authors
- June Chul Roh (1 shared paper)Adeel Ahmad (1 shared paper)Yingjian Li (2 shared papers)Youhua Liu (2 shared papers)Chunsun Dai (1 shared paper)Nicholas Ferrell (10 shared papers)Fengli Zhang (1 shared paper)Yi Zhang (6 shared papers)
- Journals
- Medicine (3 papers)Advanced Healthcare Materials (2 papers)Frontiers in Pharmacology (2 papers)Matrix Biology (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Dan Wang
99 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 161
- Nephrology 313
- Clinical Biochemistry 93
- Cardiology and Cardiovascular Medicine 304
- Biomedical Engineering 390
- Immunology 151
Countries citing papers authored by Dan Wang
This map shows the geographic impact of Dan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Wang more than expected).
Fields of papers citing papers by Dan Wang
This network shows the impact of papers produced by Dan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Wang. The network helps show where Dan Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dan Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 211 | |
| 2 | 2019 | 150 | |
| 3 | 2011 | 135 | |
| 4 | 2017 | 82 | |
| 5 | 2016 | 60 | |
| 6 | 2013 | 54 | |
| 7 | 2022 | 51 | |
| 8 | 2016 | 49 | |
| 9 | 2013 | 48 | |
| 10 | 2017 | 44 | |
| 11 | 2020 | 44 | |
| 12 | 2019 | 42 | |
| 13 | 2007 | 38 | |
| 14 | 2021 | 38 | |
| 15 | 2017 | 33 | |
| 16 | 2022 | 33 | |
| 17 | 2014 | 31 | |
| 18 | 2021 | 30 | |
| 19 | 2017 | 28 | |
| 20 | 2017 | 27 |
About Dan Wang
Dan Wang is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine, Surgery, Molecular Biology and Biomedical Engineering, having authored 110 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cardiovascular Health and Disease Prevention (13 papers), Tissue Engineering and Regenerative Medicine (9 papers), Non-Invasive Vital Sign Monitoring (8 papers), Chronic Kidney Disease and Diabetes (8 papers), Advanced Glycation End Products research (8 papers), Dialysis and Renal Disease Management (7 papers), Blood Pressure and Hypertension Studies (7 papers) and Gout, Hyperuricemia, Uric Acid (7 papers). The work is most often cited by research in Nephrology (313 citations), Clinical Biochemistry (93 citations), Cardiology and Cardiovascular Medicine (304 citations), Biomedical Engineering (390 citations) and Immunology (151 citations). Dan Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include June Chul Roh, Adeel Ahmad, Yingjian Li, Youhua Liu, Chunsun Dai, Nicholas Ferrell, Fengli Zhang, Yi Zhang, Mengyang Liu and Zhili Hao. Their work appears in journals such as Medicine, Advanced Healthcare Materials, Frontiers in Pharmacology, Matrix Biology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.